摘要 |
Compound of formula (I): wherein: R<SUB>1 </SUB>and R<SUB>2</SUB>, which may be identical or different, each represents hydrogen, acyl or alkyl, Ar represents aryl or heteroaryl, A represents a group selected from: R<SUB>4 </SUB>represents hydrogen or alkyl, R<SUB>5 </SUB>represents hydrogen, alkyl, aryl or heteroaryl, R<SUB>3 </SUB>represents aryl, heteroaryl, dicyclopropylmethyl or benzhydryl, or A-R<SUB>3 </SUB>represents an optionally substituted naphthyl group, with the exclusion of 2,5-dihydroxy-3-(4-methoxyphenyl)-6-(2-phenylethenyl)-1,4-benzoquinone, 2,5-dihydroxy-3-(4-methoxyphenyl)-6-(2-naphthyl)-1,4-benzoquinone and 2,5-dihydroxy-3-(2-naphthyl)-6-phenyl-1,4-benzoquinone. Medicinal products containing the same which are useful in the treatment of diseases associated with a deregulation of glycaemia. |